Home Cart 0 Sign in  
X

[ CAS No. 54450-20-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 54450-20-3
Chemical Structure| 54450-20-3
Chemical Structure| 54450-20-3
Structure of 54450-20-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 54450-20-3 ]

Related Doc. of [ 54450-20-3 ]

Alternatived Products of [ 54450-20-3 ]

Product Details of [ 54450-20-3 ]

CAS No. :54450-20-3 MDL No. :MFCD06738724
Formula : C8H5BrO2 Boiling Point : -
Linear Structure Formula :- InChI Key :UXUCDQLDYILHQI-UHFFFAOYSA-N
M.W : 213.03 Pubchem ID :10512748
Synonyms :

Calculated chemistry of [ 54450-20-3 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.12
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 43.91
TPSA : 26.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.07 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.99
Log Po/w (XLOGP3) : 2.16
Log Po/w (WLOGP) : 2.02
Log Po/w (MLOGP) : 1.47
Log Po/w (SILICOS-IT) : 2.85
Consensus Log Po/w : 2.1

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.93
Solubility : 0.253 mg/ml ; 0.00119 mol/l
Class : Soluble
Log S (Ali) : -2.34
Solubility : 0.963 mg/ml ; 0.00452 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.44
Solubility : 0.0781 mg/ml ; 0.000366 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.86

Safety of [ 54450-20-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 54450-20-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 54450-20-3 ]
  • Downstream synthetic route of [ 54450-20-3 ]

[ 54450-20-3 ] Synthesis Path-Upstream   1~15

  • 1
  • [ 872191-26-9 ]
  • [ 54450-20-3 ]
YieldReaction ConditionsOperation in experiment
93%
Stage #1: at 150℃; for 6 h;
Stage #2: With hydrogenchloride In methanol; water at 100℃; for 2 h;
To a solution of compound S4 (37.4 g, 0.136 mol) in acetic acid (110 ml) was subsequently added acetic anhydride (380 ml, 10 v/m) and sodium acetate (74g, 2 m/m). The resulting suspension was heated at reflux for 6 h. Then acetic anhydride and acetic acid were removed by vacuum concentration. The residue was cooled and poured in to water, subsequently extracted with ethyl acetate. The organic extracts were concentrated. To the residue in methanol was added 1N HCl (150 ml). The resulting suspension was heated at 100 °C for 2 h and concentratedthe resulting red precipitate was recovered by filtration, and dried at infrared to give white solid S5 (yield: 93percent). 1H-NMR (300MHzCDCl3): δ ppm 4.88 (s, 2H), 7.28 (d, J = 8.76 Hz, 1H), 7.79 (d, J = 2.01 Hz, 1H), 7.84 (dd, J = 8.76, 2.01 Hz, 1H).
Reference: [1] Bioorganic and Medicinal Chemistry, 2018, vol. 26, # 15, p. 4537 - 4543
  • 2
  • [ 872191-29-2 ]
  • [ 54450-20-3 ]
YieldReaction ConditionsOperation in experiment
86.9% With hydrogenchloride In methanol; water Synthesis of 5-bromo-3(2H)-benzofuranone (Compound 4)
A mixture of Compound 3, methanol (10 mL), purified water (5 mL), and 1 N HCl (2 mL) was heated to reflux for 3 h under stirring.
After completion of the reaction, the reaction solution was cooled and purified water (100 ml) was added thereto.
The crystals formed were collected by vacuum filtration to give Compound 4. Yield: 0.50 g (yield rate: 86.9 percent) 1H NMR (300 MHz, CDCl3) d 4.67 (s, 2H), 7.06 (d, J = 9.0 Hz, 1H), 7.69 (dd, J = 2.1, 2.1 Hz, 1H), 7.79 (d, J = 2.1 Hz, 1H).
Reference: [1] Patent: EP2113258, 2009, A1,
[2] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 22, p. 6354 - 6363
  • 3
  • [ 104-92-7 ]
  • [ 79-04-9 ]
  • [ 54450-20-3 ]
YieldReaction ConditionsOperation in experiment
53%
Stage #1: With aluminum (III) chloride In dichloromethane at 25 - 40℃; for 78.75 h; Inert atmosphere
Stage #2: With sodium acetate In ethanol for 2 h; Reflux; Inert atmosphere
General procedure: To a solution of 1-fluoro-4-methoxybenzene (48, 10.0 mmol) indichloromethane (30 mL) was added chloroacetyl chloride(11.0 mmol) at 0 °C. After stirring for 15 min, the reaction mixturewas added anhydrous aluminium chloride (11.0 mmol) over 30 min. After stirring for 6 h at 40 °C, the reaction mixture was cool to rt. After stirring for 72 h at rt, the reaction mixture was poured into ice water (50 mL) and extracted with dichloromethane(3 30 mL). The combined organic phases were washed with brine,dried over anhydrous Na2SO4, and evaporated under vacuum without further purification. To a solution of the residue in ethanol(30 mL) was added anhydrous sodium acetate (20.0 mmol). After refluxing for 2 h, the reaction mixture was cooled to rt and concentrated under vacuum. The residue was dissolved in water (50 mL) and extracted with dichloromethane (3 40 mL). The combined organic phases were washed with brine, dried over anhydrous Na2SO4, and evaporated under vacuum. The crude mixture was purified by flash chromatography on silica gel (petroleum ether/ethyl acetate 40/1) to afford the title compound. Bright yellow solid, yield 60percent;
Reference: [1] European Journal of Medicinal Chemistry, 2017, vol. 130, p. 195 - 208
  • 4
  • [ 100959-21-5 ]
  • [ 54450-20-3 ]
Reference: [1] Journal of the American Chemical Society, 2007, vol. 129, # 26, p. 8328 - 8332
[2] Patent: US2011/28414, 2011, A1, . Location in patent: Page/Page column 17
  • 5
  • [ 67029-74-7 ]
  • [ 54450-20-3 ]
Reference: [1] Organic Letters, 2009, vol. 11, # 1, p. 17 - 20
  • 6
  • [ 106-41-2 ]
  • [ 54450-20-3 ]
Reference: [1] Journal of the American Chemical Society, 2007, vol. 129, # 26, p. 8328 - 8332
  • 7
  • [ 104-92-7 ]
  • [ 54450-20-3 ]
Reference: [1] Patent: US2011/28414, 2011, A1,
  • 8
  • [ 2476-35-9 ]
  • [ 54450-20-3 ]
Reference: [1] Synlett, 2002, # 3, p. 501 - 503
[2] Journal of Labelled Compounds and Radiopharmaceuticals, 1996, vol. 38, # 9, p. 863 - 871
  • 9
  • [ 62910-63-8 ]
  • [ 54450-20-3 ]
Reference: [1] Synlett, 2002, # 3, p. 501 - 503
  • 10
  • [ 7120-41-4 ]
  • [ 54450-20-3 ]
Reference: [1] Journal of Labelled Compounds and Radiopharmaceuticals, 1996, vol. 38, # 9, p. 863 - 871
  • 11
  • [ 119-36-8 ]
  • [ 54450-20-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2018, vol. 26, # 15, p. 4537 - 4543
  • 12
  • [ 4068-76-2 ]
  • [ 54450-20-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2018, vol. 26, # 15, p. 4537 - 4543
  • 13
  • [ 186581-53-3 ]
  • [ 62910-63-8 ]
  • [ 54450-20-3 ]
Reference: [1] Journal of Labelled Compounds and Radiopharmaceuticals, 1996, vol. 38, # 9, p. 863 - 871
  • 14
  • [ 867-13-0 ]
  • [ 54450-20-3 ]
  • [ 200204-85-9 ]
Reference: [1] Patent: US6127388, 2000, A,
  • 15
  • [ 54450-20-3 ]
  • [ 1099-45-2 ]
  • [ 200204-85-9 ]
Reference: [1] Journal of the American Chemical Society, 2007, vol. 129, # 26, p. 8328 - 8332
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 54450-20-3 ]

Bromides

Chemical Structure| 55580-08-0

[ 55580-08-0 ]

7-Bromo-3,4-dihydrobenzo[b]oxepin-5(2H)-one

Similarity: 0.89

Chemical Structure| 201809-69-0

[ 201809-69-0 ]

6-Bromobenzofuran-3(2H)-one

Similarity: 0.87

Chemical Structure| 18442-22-3

[ 18442-22-3 ]

7-Bromochroman-4-one

Similarity: 0.86

Chemical Structure| 519018-52-1

[ 519018-52-1 ]

7-Bromobenzofuran-3(2H)-one

Similarity: 0.86

Chemical Structure| 56341-31-2

[ 56341-31-2 ]

2-Bromo-9H-xanthen-9-one

Similarity: 0.84

Ketones

Chemical Structure| 55580-08-0

[ 55580-08-0 ]

7-Bromo-3,4-dihydrobenzo[b]oxepin-5(2H)-one

Similarity: 0.89

Chemical Structure| 201809-69-0

[ 201809-69-0 ]

6-Bromobenzofuran-3(2H)-one

Similarity: 0.87

Chemical Structure| 18442-22-3

[ 18442-22-3 ]

7-Bromochroman-4-one

Similarity: 0.86

Chemical Structure| 519018-52-1

[ 519018-52-1 ]

7-Bromobenzofuran-3(2H)-one

Similarity: 0.86

Chemical Structure| 56341-31-2

[ 56341-31-2 ]

2-Bromo-9H-xanthen-9-one

Similarity: 0.84

Related Parent Nucleus of
[ 54450-20-3 ]

Benzofurans

Chemical Structure| 201809-69-0

[ 201809-69-0 ]

6-Bromobenzofuran-3(2H)-one

Similarity: 0.87

Chemical Structure| 519018-52-1

[ 519018-52-1 ]

7-Bromobenzofuran-3(2H)-one

Similarity: 0.86

Chemical Structure| 7169-34-8

[ 7169-34-8 ]

Benzofuran-3(2H)-one

Similarity: 0.83

Chemical Structure| 120973-72-0

[ 120973-72-0 ]

2-Benzoylbenzofuran-5-carbaldehyde

Similarity: 0.79

Chemical Structure| 170730-06-0

[ 170730-06-0 ]

1-(2,3-Dihydro-7-benzofuranyl)ethanone

Similarity: 0.75